Lung Cancer Clinical Trial

Study to Evaluate Percussive Ventilation Breathhold to Improve Lung Stereotactic Ablative Radiotherapy

Summary

The purpose of this research is to evaluate and determine the rate of successful administration of Percussive ventilation breathhold (PVB) to allow for more accurate radiotherapy for lung tumors.

View Full Description

Full Description

Primary Objective(s)

To determine the rate of successful administration of the PVB-SABR in lung cancer patients.
To determine the rate of successful administration of PVB in healthy volunteers for 5 minutes

Secondary Objective(s)

To determine the rate of successful administration of PVB in healthy volunteers for 10 minutes as well as for patients' successfully completing the technique for 5 and 10 minutes.
To collect exploratory clinical (both arms) and dosimetric data from lung cancer patients using PVB-SABR.
To collect patient-reported data on hospital-associated anxiety, motivation to learn the technique from the educational materials, and subjective evaluation of those materials

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Healthy volunteers age 18 or older
Patients with a diagnosis of primary lung cancer or lung metastases of any primary tumor origin
Patients deemed clinically eligible to be treated with standard of care lung SABR for patient arm
Patients of any gender age 18 or older
Patients with ECOG Performance Status 1-2 and select patients with Performance Status 3 deemed to be suitable candidates based on common sense clinical judgment on the risks versus benefits of SABR

Exclusion Criteria:

No Pregnant Women
Patients clinically deemed ineligible for standard of care lung SABR treatment for the patient arm (for example, excessive tumor size, severe pulmonary fibrosis are relative contraindications for lung SABR and are part of standard of care clinical decision making).
Patients with newly-developed pneumothorax
Patients with critical acute illness precluding SABR in the judgment of the treating physician (examples could include active pulmonary embolism and infection requiring inpatient care)
Patients with ECOG Performance Status 4

Study is for people with:

Lung Cancer

Estimated Enrollment:

20

Study ID:

NCT05283564

Recruitment Status:

Recruiting

Sponsor:

Stanford University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Stanford Cancer Institute
Palo Alto California, 94305, United States More Info
Kaitlin Barnick
Contact
650-497-8966
[email protected]
Brianna Lau
Contact
650-725-4796
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

20

Study ID:

NCT05283564

Recruitment Status:

Recruiting

Sponsor:


Stanford University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.